Canada markets open in 1 hour 30 minutes

Nemaura Medical Inc. (NMRD)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.5500-0.0800 (-2.20%)
At close: 4:00PM EDT

Nemaura Medical Inc.

57 West 57th Street
New York, NY 10019
United States
646 416 8000

IndustryMedical Devices
Full Time Employees17

Key Executives

NameTitlePayExercisedYear Born
Dr. Dewan Fazlul Hoque ChowdhuryChairman, CEO, Pres & Interim CFO103.77kN/A1973
Mr. Christopher J. AveryVP of Global Bus. OperationsN/AN/A1963
Mr. Bashir TimolChief Bus. Officer & DirectorN/AN/A1974
Ms. Kathryn FarrarFinancial ControllerN/AN/A1976
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. The company provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Corporate Governance

Nemaura Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.